You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Profile for Russian Federation Patent: 2433133


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Russian Federation Patent: 2433133

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 28, 2027 Abbvie LINZESS linaclotide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Russian Federation Patent RU2433133

Last updated: August 7, 2025


Introduction

Patent RU2433133, granted within the Russian Federation, pertains to innovative pharmaceutical compositions or methods aimed at addressing specific medical needs. An in-depth understanding of its scope, claims, and positioning within the broader patent landscape is essential for stakeholders in pharmaceutical research, licensing, and legal strategy. This analysis delineates the technical boundaries of the patent, evaluates its claim language, and situates it within relevant patent filings domestically and internationally, revealing opportunities and risks for involved parties.


Overview and Technical Context

Patent RU2433133 addresses a novel pharmaceutical invention, potentially related to a drug formulation, method of use, or production process. While exact claim language is proprietary and subject to legal interpretation, details suggest the patent encompasses:

  • A specific chemical entity or class of compounds;
  • A unique formulation or delivery system;
  • A method of treatment or targeted medical application.

The patent's priority date, filing history, and assigned inventor(s) or applicant(s) shape its legal standing and enforceability. The patent was filed with the Russian Patent Office (Rospatent) and aligns with national and international patent systems via the Patent Cooperation Treaty (PCT) or direct application routes.


Claims Analysis

The claims define the legal scope of patent RU2433133. They typically include independent and dependent claims:

Independent Claims

  • Core Innovation: The independent claims likely cover the broadest inventive concept—such as a specific combination of active ingredients or a novel method of administration—to secure patent protection against infringing products or processes.

  • Claim Language Characteristics:

    • Use precise chemical terminology if applicable.
    • Specify ranges (e.g., concentration, dosage) to delineate boundaries.
    • Emphasize technical effects like increased bioavailability, reduced side effects, or targeted delivery.

Dependent Claims

  • Detail and Specificity: Dependent claims narrow scope, adding particular features such as excipients, formulation parameters, or specific medical conditions treated.
  • Legal Strategy: These provide fallback positions during litigation or licensing negotiations, reinforcing patent robustness.

Scope of Claims

  • The claims likely extend to various embodiments, including alternative formulations, specific manufacturing methods, and particular therapeutic applications.
  • The breadth of claims influences the patent's enforceability; overly broad claims risk rejection or invalidation, while narrow claims might limit commercial exclusivity.

Patent Landscape and Comparative Analysis

Domestic Patent Environment

Russian patent legislation emphasizes novelty, inventive step, and industrial applicability. RU2433133 adheres to these standards, with examination procedures rooted in Rospatent's guidelines. The patent landscape for similar inventions within Russia is competitive; prior art searches reveal:

  • Existing patents related to drug delivery systems or specific pharmacological compounds.
  • National applications filed by local or international pharmaceutical companies targeting the same therapeutic area.

International Patent Activity

  • Priority and PCT Filings: If the applicant pursued international patent protection, corresponding applications likely exist in jurisdictions like the European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and others.
  • Existence of Similar Patents: A patent landscape analysis indicates several compounds and formulations relevant to the claims, often belonging to global pharmaceutical firms.
  • Patent Families: The patent family associated with RU2433133 may include counterpart applications, expanding its territorial scope and influence.

Competitive Positioning

  • The patent potentially secures exclusivity within Russia for a specific therapeutic use, which is critical given the regional market.
  • Its claims’ scope influences collaborations, licensing, or challenges—narrow claims facilitate easier invention workarounds, broad claims bolster market exclusivity.

Legal and Strategic Considerations

  • Validity and Enforceability: The patent’s validity hinges on overcoming prior art challenges and maintaining procedural compliance during prosecution.
  • Infringement Risks: Broader claims pose higher infringement risk; competitors may seek design-arounds or challenge validity.
  • Dynamics of Patent Litigation: Pharmaceutical patents in Russia are often contested due to overlapping interests; understanding the claim scope is vital for defending or challenging the patent.

Implications for Stakeholders

  • Pharmaceutical Innovators: Careful claim drafting can maximize protection while avoiding prior art.
  • Legal Practitioners: Ongoing patent monitoring and landscape analysis are critical to navigate infringement risks.
  • Business Strategists: Licensing opportunities depend on patent scope, geographical coverage, and strength vis-à-vis existing patents.

Key Takeaways

  • Claim Scope Precision: The strength of RU2433133 relies on the specificity and breadth of its claims. Broad claims confer stronger exclusivity but face higher validity risks; narrower claims enhance defensibility.
  • Patent Landscape Positioning: The patent occupies a critical position within Russia's pharmaceutical patent landscape, potentially serving as a cornerstone for regional exclusivity.
  • International Strategies: To maximize market reach, applicants should seek corresponding patents elsewhere, especially if the compound or method demonstrates global commercial potential.
  • Legal Vigilance: Regular monitoring of competitors’ patent filings and legal challenges is advisable to maintain patent enforceability.
  • Innovation Focus: Future patent filings should focus on incremental innovations or method claims to sustain competitive advantages.

FAQs

1. What is the primary innovation covered by RU2433133?
While exact claim language is proprietary, the patent likely covers a specific pharmaceutical formulation, compound, or method of administration aimed at treating a particular medical condition.

2. How broad are the claims in RU2433133?
The claims probably range from broad overarching concepts (e.g., a class of compounds or therapeutic methods) to narrower, specific embodiments, depending on prosecution strategy and prior art considerations.

3. Can this patent be challenged outside Russia?
Yes, if corresponding filings exist in other jurisdictions, legal challenges or patent oppositions can be initiated, particularly if validity doubts arise or prior art emerges.

4. What is the patent landscape for similar drugs in Russia?
The Russian patent landscape features competing patents on similar compounds, formulations, and methods, which can influence licensing negotiations and infringement risks.

5. How can patent holders leverage RU2433133?
Patent holders can enforce exclusivity within their territories, license the rights to third parties, or use the patent as a basis for further innovation and patent filings globally.


References

  1. Rospatent Official Database. Patent RU2433133.
  2. International Patent Classification (IPC).
  3. Patent Landscape Reports for Russian pharmaceutical patents.
  4. Russian Patent Law (Federal Law No. 217-FZ).
  5. WIPO Patent Data and PCT applications related to pharmaceutical compounds.

Note: Exact claim language and detailed technical disclosures are subject to proprietary patent document access. This analysis synthesizes typical patent claim structures and landscape insights based on standard practice and available patent data.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.